SERPINE1 and metabolic dysfunction-associated steatotic liver disease: Strong correlations between PAI-1 serum levels and TGL serum levels were reported in patients with dyslipidemia, obesity, metabolic syndrome, type 2 diabetes mellitus, and nonalcoholic fatty liver disease [77,78,79,80].